| Annie Lam, MD | |
|
9701 Harmon Rd Ste 141, Fort Worth, TX 76177-7602 | |
| (214) 947-5400 | |
| Not Available |
| Full Name | Annie Lam |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 9701 Harmon Rd Ste 141, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124556873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10061107 (Texas) | Secondary |
| 207Q00000X | Family Medicine | S4329 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Alliance | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Clinic Of North Texas, Pllc | 9830084540 | 206 |
News Archive
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC).
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).
A study of how chronically ill teenagers manage their privacy found that teen patients spend a great deal of time online and guard their privacy very consciously. "Not all my friends need to know": a qualitative study of teenage patients, privacy and social media, was published this summer in the Journal of the American Medical Informatics Association and co-authored by Norwegian and Canadian researchers.
Clinical Data, Inc. today announced that the Company has closed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic, Inc. for $15.5 million. The sale completes Clinical Data's transformation into a pharmaceutical company with a deep product pipeline, including two promising late-stage compounds, the most advanced of which is vilazodone, a new treatment in development for Major Depressive Disorder.
A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.
› Verified 2 days ago
| Entity Name | Medical Clinic Of North Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033167234 PECOS PAC ID: 9830084540 Enrollment ID: O20040430001258 |
News Archive
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC).
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).
A study of how chronically ill teenagers manage their privacy found that teen patients spend a great deal of time online and guard their privacy very consciously. "Not all my friends need to know": a qualitative study of teenage patients, privacy and social media, was published this summer in the Journal of the American Medical Informatics Association and co-authored by Norwegian and Canadian researchers.
Clinical Data, Inc. today announced that the Company has closed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic, Inc. for $15.5 million. The sale completes Clinical Data's transformation into a pharmaceutical company with a deep product pipeline, including two promising late-stage compounds, the most advanced of which is vilazodone, a new treatment in development for Major Depressive Disorder.
A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Annie Lam, MD 9701 Harmon Rd Ste 141, Fort Worth, TX 76177-7602 Ph: () - | Annie Lam, MD 9701 Harmon Rd Ste 141, Fort Worth, TX 76177-7602 Ph: (214) 947-5400 |
News Archive
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC).
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).
A study of how chronically ill teenagers manage their privacy found that teen patients spend a great deal of time online and guard their privacy very consciously. "Not all my friends need to know": a qualitative study of teenage patients, privacy and social media, was published this summer in the Journal of the American Medical Informatics Association and co-authored by Norwegian and Canadian researchers.
Clinical Data, Inc. today announced that the Company has closed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic, Inc. for $15.5 million. The sale completes Clinical Data's transformation into a pharmaceutical company with a deep product pipeline, including two promising late-stage compounds, the most advanced of which is vilazodone, a new treatment in development for Major Depressive Disorder.
A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.
› Verified 2 days ago
Jonathan A Lazarini, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Fort Worth, TX 76104 Phone: 903-353-2265 | |
Mrs. Adeline Galvez, Family Medicine Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 270, Fort Worth, TX 76104 Phone: 817-250-4987 | |
Fomundam Newnton Mbuh, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 4759 South Fwy Ste 101, Fort Worth, TX 76115 Phone: 817-382-0005 | |
Dr. Joane Baumer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Family Medicine Center, Fort Worth, TX 76104 Phone: 817-335-1034 | |
Evelyn Tobias-merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 Stadium Dr, Fort Worth, TX 76109 Phone: 817-257-7940 | |
Dr. Michael David Carletti, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Montgomery St, Fort Worth, TX 76107 Phone: 817-735-0278 | |
Jonathan Patrick Angel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Beach St Ste 104, Fort Worth, TX 76111 Phone: 817-831-1750 Fax: 817-831-1750 |